Clinical Trial: Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Transplant-Related Disorder
Study Type: INTERVENTIONAL
Official Title: A Prospective, Single-arm Clinical Trial of Prevention of Severe Acute Graft-versus-host Disease After Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation Using a daGOAT Model
Brief Summary:
To evaluate the efficacy and safety of ruxolitinib for prophylactic therapy of adult patients who are predicted to have a high risk for developing severe acute graftversus-host disease (aGVHD) by the dynamic aGVHD Onset Anticipation Tianjin (daGOAT) model.
Read more